SCHEMBL21252380

SCHEMBL21252380

CCN1CCN(c2ccc(NCc3cc4cnc(-c5c(F)c(OC)cc(OC)c5F)cc4cn3)c(NC=O)c2)CC1

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 11/20 0.40
▸ FGFR4 P22455 9/20 0.40
▸ EGFR P00533 1/20 0.36
▸ MAP4K1 Q92918 2/20 0.36
▸ PDGFRB P09619 1/20 0.35
▸ PDGFRA P16234 1/20 0.35
▸ FGFR2 P21802 2/20 0.35
▸ FGFR3 P22607 1/20 0.35
▸ MET P08581 1/20 0.34
▸ CHEK1 O14757 1/20 0.34
▸ ALK Q9UM73 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21251976 0.79 FGFR1 (0.50) FGFR1FGFR4PDGFRBPDGFRAFGFR2
SCHEMBL21251769 0.78 FGFR1 (0.57) FGFR1FGFR4PDGFRAFGFR2FGFR3
SCHEMBL20330520 0.76 FGFR1 (0.65) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL30044812 0.76 FGFR1 (0.65) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL24488253 0.72 FGFR1 (0.35) FGFR1FGFR4EGFRPDGFRBPDGFRA
SCHEMBL21251808 0.70 FGFR1 (0.49) FGFR1FGFR4PDGFRBPDGFRAFGFR2
SCHEMBL30046401 0.69 FGFR1 (0.66) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL20330528 0.69 FGFR1 (0.66) FGFR1FGFR4EGFRFGFR2FGFR3
SCHEMBL20330516 0.67 FGFR4 (0.74) FGFR1FGFR4FGFR2FGFR3
SCHEMBL30045115 0.67 FGFR4 (0.74) FGFR1FGFR4FGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524603-A1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2019-08-14 — — EP disclosed
Send feedback